San Diego StrokeNet Regional Coordinating Center

圣地亚哥RCC致力于实现StrokeNet的目标，即提供“效率”，“注册”和“服务”。 通过创建优化的网络、增加试用注册和加强职业发展来进行“培训”。 这项应用的结果将通过发现急性， 中风的预防、康复、恢复、神经再生以及成像和生物标志物技术。 UCSD准备继续为StrokeNet做出贡献，并支持NINDS寻求知识的使命 关于大脑和神经系统，以减轻神经系统疾病的负担。 项目：UCSD参与了SPOTRIAS，StrokeNet，NIH和工业试验的各个领域， 领导并参与了50多项中风试验。该网络是从一个当地的 网络，随着时间的推移扩大，现在包括30个中心跨越三个国家。所有站点都有活动的Master 试用协议和信赖协议到位。加州大学圣地亚哥分校中风中心再次参与支持 院长、主席、IRB、合同办公室、CTRI、艾德、EMS和网络研究者的意见。 研究：下一个周期将侧重于在30个RCC中心进行试验和招募参与者。 RCC-12拥有强大的潜在网络调查人员库，他们已经建立了基础设施， 等待参加网络试验。我们也有能力在儿科进行试验， 戒毒所加州大学圣地亚哥分校已经提交了试验的想法，并有其他人在开发的建议进入网络。 领导：UCSD已指定PI（Meyer）和替代PI（Hemmen），每个人都有资格 有效服务。UCSD是急性卒中工作组和神经介入咨询中心的成员。 以马克思在多学科临床试验团队中，来自各个学科的专家可以 在中风管理的不同领域合作进行试验。特别适合于以下专业领域的审判： 研究人员由RCC-PI根据专业领域分配。 职业提升：自2005年以来，中风中心一直致力于为学员提供职业指导。 1987. StrokeNet职业发展总监（Hemmen）还担任以下项目的导师 独立的研究活动。该培训计划的重点是研究中风的整个频谱 在乎教学讲座和研讨会提供了广泛的主题。 管理：UCSD在生产高质量的研究，出版物和NIH方面取得了巨大的成功 试验入组应接受标准操作规程（SOP）培训。UCSD中风 中心尽可能优先考虑StrokeNet和NIH资助的试验。分配网格通过以下方式减轻偏差 公平地指导试用产品。在过去的30年里，UCSD中风中心成功地进行了试验， 在中风护理的全方位，是一个理想的选择，继续领导中风网RCC。

The San Diego RCC is dedicated to the StrokeNet aims of delivering “Efficiency”, “Enrollments”, and “Training” by creating an optimized network, increasing trial enrollments, and enhancing career development. The results of this application will impact the stroke research field by enabling the discovery of acute, preventative, rehabilitation, recovery, neural regeneration, and imaging and biomarker techniques for stroke. UCSD is poised to continue to contribute to StrokeNet and support the NINDS' mission to seek knowledge about the brain and nervous system to reduce the burden of neurological disease. Program: UCSD has participated in SPOTRIAS, StrokeNet, NIH, and industry trials in various areas of stroke with leadership and participation in over 50 stroke trials. The network has developed out of a local network, expanded over time and now includes 30 centers spanning three states. All sites have active Master Trial Agreements and Reliance Agreements in place. The UCSD Stroke Center has again engaged the support of the Dean, Chair, IRB, Contracting Office, CTRI, ED, EMS, and network investigators for this proposal. Research: The next cycle will focus on conducting trials and enrolling participants in the 30 RCC centers. The RCC-12 has a strong pool of potential network investigators who have set up their infrastructure and are awaiting to participate in a network trial. We also have the proven capacity to perform trials in pediatrics and rehab. UCSD has submitted trial ideas and as has others in development for proposal into the network. Leadership: UCSD has designated a PI (Meyer) and substitute PI (Hemmen), each with qualifications to serve effectively. UCSD serves on the Acute Stroke Working Group and the Neuro-Interventional Advisory Committee. In the multidisciplinary clinical trials' team, experts from various disciplines are available to collaborate on trials in diverse arenas of stroke management. Trials particularly suited to areas of expertise of research faculty are assigned by the RCC-PI based on area of expertise. Career Enhancement: The Stroke Center has had full commitment to career guidance for trainees since 1987. The StrokeNet Career Enhancement Director (Hemmen) also serves as the fellow mentor for independent research activities. The training program focuses on research for the entire spectrum of stroke care. Didactic lectures and seminars are offered in diffuse topics. Administration: UCSD has had great success in producing high quality research, publications, and NIH trial enrollments due training on and following standard operating procedures (SOPs). The UCSD Stroke Center prioritizes StrokeNet and NIH funded trials as possible. Allocations grids mitigate against bias by guiding trial offerings fairly. Over the past 30 years, the UCSD Stroke Center has successfully performed trials in the full spectrum of stroke care, and is an ideal choice to continue leading a StrokeNet RCC.